DVN
43
7
KMX
47
4
ILMN
64
4
NVDA
54
2
SEE
45
-4
HP
36
3
INTC
41
5
NWSA
73
15
BXP
47
3
MSI
63
3
CNP
44
8
FDX
30
-9
WHR
64
3
PEP
47
3
MDT
59
-3
DTE
47
2
AMGN
47
8
WFC
66
-5
AME
62
3
KEY
33
-4
DVN
43
7
KMX
47
4
ILMN
64
4
NVDA
54
2
SEE
45
-4
HP
36
3
INTC
41
5
NWSA
73
15
BXP
47
3
MSI
63
3
CNP
44
8
FDX
30
-9
WHR
64
3
PEP
47
3
MDT
59
-3
DTE
47
2
AMGN
47
8
WFC
66
-5
AME
62
3
KEY
33
-4
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Buy
59

UTHR
United Therapeutics

Last Price:
376.96
Seasonality Move:
11.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

United Therapeutics Price Quote

$376.96
+0.16 (+0.79%)
(Updated: November 5, 2024 at 5:46 AM ET)

United Therapeutics Key Stats

Buy
59
United Therapeutics (UTHR) is a Buy
Day range:
$371.32 - $379.51
52-week range:
$208.62 - $379.51
Dividend yield:
0%
P/E ratio:
19.02
P/S ratio:
6.69
P/B ratio:
2.76%
Volume:
321.8K
Avg. volume:
324.7K
1-year change:
67.89%
Market cap:
$16.8B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 382.29
Upside from Last Price: 1.46%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    81.4M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders